In the last 12 months, insiders at Axogen, Inc. ($AXGN) filed 376 transactions with the SEC: 4 open-market purchases totaling $215,453 and 76 sales totaling $17,306,412. Net insider sentiment: net selling.
Axogen, Inc. operates in the Electromedical & electrotherapeutic apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Burke William P. Mr. (Director) — 37 transactions totaling $3,708,807
- DALE MICHAEL D (Chief Executive Officer) — 5 transactions totaling $2,668,137
- Wendell Amy McBride (Director) — 25 transactions totaling $2,053,058
- DeVinney Erick Wayne (Chief Innovation Officer) — 37 transactions totaling $2,048,191
- Hartley Lindsey Marie (CFO) — 22 transactions totaling $1,929,198
View all SEC Filings for Axogen, Inc. (AXGN).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | DeVinney Erick Wayne | Chief Innovation Officer | F | Common Stock | 2870 | $32.84 | 256,427.0000 | 49,088,436 | 1.11% | 0.01% |
| March 16, 2026 | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 6363 | $0.00 | 259,297.0000 | 49,088,436 | 2.52% | 0.01% |
| March 16, 2026 | Hartley Lindsey Marie | CFO | M | Restricted Stock Units | 5000 | $0.00 | 5,000.0000 | 49,088,436 | 9999.99% | 0.01% |
| March 16, 2026 | Hartley Lindsey Marie | CFO | M | Restricted Stock Units | 4000 | $0.00 | 4,000.0000 | 49,088,436 | 9999.99% | 0.01% |
| March 16, 2026 | Hartley Lindsey Marie | CFO | F | Common Stock | 1968 | $32.84 | 60,734.0000 | 49,088,436 | 3.14% | 0.00% |
| March 16, 2026 | Hartley Lindsey Marie | CFO | M | Common Stock | 5000 | $0.00 | 62,702.0000 | 49,088,436 | 8.67% | 0.01% |
| March 16, 2026 | Hartley Lindsey Marie | CFO | F | Common Stock | 1574 | $32.84 | 57,702.0000 | 49,088,436 | 2.66% | 0.00% |
| March 16, 2026 | Hartley Lindsey Marie | CFO | M | Common Stock | 4000 | $0.00 | 59,276.0000 | 49,088,436 | 7.24% | 0.01% |
| March 16, 2026 | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 11575 | $0.00 | 11,575.0000 | 49,088,436 | 9999.99% | 0.02% |
| March 16, 2026 | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 6363 | $0.00 | 6,363.0000 | 49,088,436 | 9999.99% | 0.01% |
| March 16, 2026 | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 5221 | $32.84 | 262,781.0000 | 49,088,436 | 1.95% | 0.01% |
| March 16, 2026 | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 11575 | $0.00 | 268,002.0000 | 49,088,436 | 4.51% | 0.02% |
| Feb. 26, 2026 | Began Marc A | EVP & General Counsel | A | Restricted Stock Units | 23000 | $0.00 | 23,000.0000 | 49,088,436 | 9999.99% | 0.05% |
| March 1, 2026 | Began Marc A | EVP & General Counsel | M | Restricted Stock Units | 11250 | $0.00 | 11,250.0000 | 49,088,436 | 9999.99% | 0.02% |
| Feb. 26, 2026 | DeVinney Erick Wayne | Chief Innovation Officer | F | Common Stock | 10702 | $31.90 | 264,210.0000 | 49,088,436 | 3.89% | 0.02% |
| March 1, 2026 | DeVinney Erick Wayne | Chief Innovation Officer | F | Common Stock | 11276 | $30.65 | 252,934.0000 | 49,088,436 | 4.27% | 0.02% |
| Feb. 26, 2026 | DeVinney Erick Wayne | Chief Innovation Officer | A | Restricted Stock Units | 23000 | $0.00 | 23,000.0000 | 49,088,436 | 9999.99% | 0.05% |
| Feb. 26, 2026 | Began Marc A | EVP & General Counsel | A | Common Stock | 33780 | $0.00 | 52,065.0000 | 49,088,436 | 184.74% | 0.07% |
| Feb. 26, 2026 | Began Marc A | EVP & General Counsel | F | Common Stock | 8753 | $31.90 | 43,312.0000 | 49,088,436 | 16.81% | 0.02% |
| March 1, 2026 | Began Marc A | EVP & General Counsel | M | Common Stock | 11250 | $0.00 | 54,562.0000 | 49,088,436 | 25.97% | 0.02% |
| March 1, 2026 | Began Marc A | EVP & General Counsel | F | Common Stock | 4427 | $30.65 | 50,135.0000 | 49,088,436 | 8.11% | 0.01% |
| Feb. 26, 2026 | Kemp Jens | Chief Marketing Officer | A | Common Stock | 50670 | $0.00 | 94,817.0000 | 49,088,436 | 114.78% | 0.10% |
| Feb. 26, 2026 | Kemp Jens | Chief Marketing Officer | F | Common Stock | 15414 | $31.90 | 79,403.0000 | 49,088,436 | 16.26% | 0.03% |
| March 1, 2026 | Kemp Jens | Chief Marketing Officer | F | Common Stock | 2952 | $30.65 | 76,451.0000 | 49,088,436 | 3.72% | 0.01% |
| Feb. 26, 2026 | Kemp Jens | Chief Marketing Officer | A | Restricted Stock Units | 23000 | $0.00 | 23,000.0000 | 49,088,436 | 9999.99% | 0.05% |
| Feb. 26, 2026 | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 33780 | $0.00 | 274,912.0000 | 49,088,436 | 14.01% | 0.07% |
| Feb. 26, 2026 | Hartley Lindsey Marie | CFO | A | Common Stock | 17453 | $0.00 | 61,906.0000 | 49,088,436 | 39.26% | 0.04% |
| Feb. 26, 2026 | Hartley Lindsey Marie | CFO | F | Common Stock | 6630 | $31.90 | 55,276.0000 | 49,088,436 | 10.71% | 0.01% |
| Feb. 26, 2026 | Hartley Lindsey Marie | CFO | A | Restricted Stock Units | 23000 | $0.00 | 23,000.0000 | 49,088,436 | 9999.99% | 0.05% |
| Feb. 26, 2026 | DALE MICHAEL D | Chief Executive Officer | A | Restricted Stock Units | 98000 | $0.00 | 98,000.0000 | 49,088,436 | 9999.99% | 0.20% |
| Feb. 22, 2026 | Hartley Lindsey Marie | CFO | F | Common Stock | 6704 | $35.38 | 44,453.0000 | 49,088,436 | 13.10% | 0.01% |
| Feb. 22, 2026 | Hartley Lindsey Marie | CFO | A | Restricted Stock Units | 17500 | $0.00 | 17,500.0000 | 49,088,436 | 9999.99% | 0.04% |
| Feb. 22, 2026 | Hartley Lindsey Marie | CFO | A | Common Stock | 17500 | $0.00 | 51,157.0000 | 49,088,436 | 52.00% | 0.04% |
| Dec. 16, 2025 | Wendell Amy McBride | Director | M | Common Stock | 18248 | $7.04 | 137,510.0000 | 49,088,436 | 15.30% | 0.04% |
| Dec. 16, 2025 | Wendell Amy McBride | Director | M | Common Stock | 20436 | $6.30 | 119,262.0000 | 49,088,436 | 20.68% | 0.04% |
| Dec. 16, 2025 | Wendell Amy McBride | Director | M | Common Stock | 5000 | $8.95 | 98,826.0000 | 49,088,436 | 5.33% | 0.01% |
| Dec. 15, 2025 | Hartley Lindsey Marie | CFO | M | Employee Stock Option (right to purchase) | 14812 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.03% |
| Dec. 15, 2025 | Hartley Lindsey Marie | CFO | S | Common Stock | 14812 | $29.86 | 31,376.0000 | 49,088,436 | 32.07% | 0.03% |
| Dec. 15, 2025 | Hartley Lindsey Marie | CFO | M | Common Stock | 14812 | $8.27 | 46,188.0000 | 49,088,436 | 47.21% | 0.03% |
| Dec. 16, 2025 | Weiler Kathy Johnson | Director | M | Employee Stock Option (right to purchase) | 21825 | $0.00 | 43,651.0000 | 49,088,436 | 33.33% | 0.04% |
| Dec. 16, 2025 | Weiler Kathy Johnson | Director | M | Employee Stock Option (right to purchase) | 18248 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.04% |
| Dec. 16, 2025 | Weiler Kathy Johnson | Director | S | Common Stock | 6580 | $29.55 | 0.0000 | 49,088,436 | 100.00% | 0.01% |
| Dec. 16, 2025 | Weiler Kathy Johnson | Director | S | Common Stock | 21825 | $29.55 | 6,580.0000 | 49,088,436 | 76.84% | 0.04% |
| Dec. 16, 2025 | Weiler Kathy Johnson | Director | S | Common Stock | 18248 | $29.55 | 28,405.0000 | 49,088,436 | 39.11% | 0.04% |
| Dec. 16, 2025 | Weiler Kathy Johnson | Director | M | Common Stock | 21825 | $6.95 | 46,653.0000 | 49,088,436 | 87.90% | 0.04% |
| Dec. 16, 2025 | Weiler Kathy Johnson | Director | M | Common Stock | 18248 | $7.04 | 24,828.0000 | 49,088,436 | 277.33% | 0.04% |
| Dec. 16, 2025 | Wendell Amy McBride | Director | M | Stock Option (right to purchase) | 18248 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.04% |
| Dec. 16, 2025 | Wendell Amy McBride | Director | M | Stock Option (right to purchase) | 20436 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.04% |
| Dec. 16, 2025 | Wendell Amy McBride | Director | M | Stock Option (right to purchase) | 5000 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.01% |
| Dec. 16, 2025 | Wendell Amy McBride | Director | S | Common Stock | 18248 | $29.31 | 93,826.0000 | 49,088,436 | 16.28% | 0.04% |
| Dec. 16, 2025 | Wendell Amy McBride | Director | S | Common Stock | 20436 | $29.31 | 112,074.0000 | 49,088,436 | 15.42% | 0.04% |
| Dec. 16, 2025 | Wendell Amy McBride | Director | S | Common Stock | 5000 | $29.31 | 132,510.0000 | 49,088,436 | 3.64% | 0.01% |
| Dec. 10, 2025 | DALE MICHAEL D | Chief Executive Officer | S | Common Stock | 25000 | $30.00 | 63,537.0000 | 49,088,436 | 28.24% | 0.05% |
| Dec. 11, 2025 | Began Marc A | EVP & General Counsel | S | Common Stock | 13222 | $30.00 | 18,285.0000 | 49,088,436 | 41.97% | 0.03% |
| Dec. 8, 2025 | Hartley Lindsey Marie | CFO | M | Employee Stock Option (right to purchase) | 5000 | $0.00 | 2,500.0000 | 49,088,436 | 66.67% | 0.01% |
| Dec. 9, 2025 | THOMAS PAUL | Director | S | Common Stock | 21399 | $29.61 | 13,528.0000 | 49,088,436 | 61.27% | 0.04% |
| Dec. 9, 2025 | TYNDALL JOSEPH A. | Director | S | Common Stock | 10860 | $30.98 | 0.0000 | 49,088,436 | 100.00% | 0.02% |
| Dec. 9, 2025 | TYNDALL JOSEPH A. | Director | S | Common Stock | 14248 | $30.98 | 10,860.0000 | 49,088,436 | 56.75% | 0.03% |
| Dec. 9, 2025 | TYNDALL JOSEPH A. | Director | M | Common Stock | 10860 | $10.95 | 25,108.0000 | 49,088,436 | 76.22% | 0.02% |
| Dec. 9, 2025 | TYNDALL JOSEPH A. | Director | M | Common Stock | 14248 | $7.04 | 14,248.0000 | 49,088,436 | 9999.99% | 0.03% |
| Dec. 9, 2025 | DALE MICHAEL D | Chief Executive Officer | S | Common Stock | 61463 | $31.21 | 88,537.0000 | 49,088,436 | 40.98% | 0.13% |
| Dec. 8, 2025 | Hartley Lindsey Marie | CFO | S | Common Stock | 11533 | $31.56 | 34,230.0000 | 49,088,436 | 25.20% | 0.02% |
| Dec. 8, 2025 | Hartley Lindsey Marie | CFO | M | Employee Stock Option (right to purchase) | 20000 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.04% |
| Dec. 9, 2025 | JOHNSON JOHN | Director | M | Stock Option (right to purchase) | 8545 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.02% |
| Dec. 8, 2025 | Hartley Lindsey Marie | CFO | M | Common Stock | 20000 | $15.22 | 40,763.0000 | 49,088,436 | 96.33% | 0.04% |
| Dec. 8, 2025 | Hartley Lindsey Marie | CFO | M | Common Stock | 5000 | $8.20 | 45,763.0000 | 49,088,436 | 12.27% | 0.01% |
| Dec. 8, 2025 | Hartley Lindsey Marie | CFO | S | Common Stock | 2854 | $31.56 | 31,376.0000 | 49,088,436 | 8.34% | 0.01% |
| Dec. 9, 2025 | Began Marc A | EVP & General Counsel | S | Common Stock | 9278 | $31.21 | 31,507.0000 | 49,088,436 | 22.75% | 0.02% |
| Dec. 9, 2025 | Kemp Jens | Chief Marketing Officer | S | Common Stock | 8156 | $31.21 | 46,030.0000 | 49,088,436 | 15.05% | 0.02% |
| Dec. 9, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 19517 | $31.21 | 241,132.0000 | 49,088,436 | 7.49% | 0.04% |
| Dec. 9, 2025 | TYNDALL JOSEPH A. | Director | M | Stock Option (right to purchase) | 10860 | $0.00 | 32,311.0000 | 49,088,436 | 25.16% | 0.02% |
| Dec. 9, 2025 | TYNDALL JOSEPH A. | Director | M | Employee Stock Option (right to purchase) | 14248 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.03% |
| Dec. 8, 2025 | JOHNSON JOHN | Director | S | Common Stock | 11802 | $31.26 | 13,141.0000 | 49,088,436 | 47.32% | 0.02% |
| Dec. 8, 2025 | JOHNSON JOHN | Director | M | Common Stock | 11891 | $6.30 | 25,032.0000 | 49,088,436 | 90.49% | 0.02% |
| Dec. 8, 2025 | JOHNSON JOHN | Director | S | Common Stock | 11891 | $31.22 | 13,141.0000 | 49,088,436 | 47.50% | 0.02% |
| Dec. 9, 2025 | JOHNSON JOHN | Director | M | Common Stock | 8545 | $6.30 | 21,686.0000 | 49,088,436 | 65.03% | 0.02% |
| Dec. 9, 2025 | JOHNSON JOHN | Director | S | Common Stock | 8545 | $29.98 | 13,141.0000 | 49,088,436 | 39.40% | 0.02% |
| Dec. 9, 2025 | JOHNSON JOHN | Director | S | Common Stock | 13141 | $29.98 | 0.0000 | 49,088,436 | 100.00% | 0.03% |
| Dec. 8, 2025 | JOHNSON JOHN | Director | M | Stock Option (right to purchase) | 11891 | $0.00 | 8,545.0000 | 49,088,436 | 58.19% | 0.02% |
| Dec. 4, 2025 | DALE MICHAEL D | Chief Executive Officer | A | Common Stock | 150000 | $0.00 | 150,000.0000 | 49,088,436 | 9999.99% | 0.31% |
| Dec. 4, 2025 | Kemp Jens | Chief Marketing Officer | A | Common Stock | 22500 | $0.00 | 54,186.0000 | 49,088,436 | 71.01% | 0.05% |
| Dec. 4, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 40000 | $0.00 | 260,649.0000 | 49,088,436 | 18.13% | 0.08% |
| Dec. 4, 2025 | Began Marc A | EVP & General Counsel | A | Common Stock | 22500 | $0.00 | 40,785.0000 | 49,088,436 | 123.05% | 0.05% |
| Nov. 10, 2025 | Burke William P. Mr. | Director | M | Common Stock | 19227 | $8.14 | 19,327.0000 | 49,088,436 | 9999.99% | 0.04% |
| Nov. 11, 2025 | Burke William P. Mr. | Director | M | Stock Option (right to purchase) | 3591 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.01% |
| Nov. 10, 2025 | Burke William P. Mr. | Director | M | Stock Option (right to purchase) | 19227 | $0.00 | 3,591.0000 | 49,088,436 | 84.26% | 0.04% |
| Nov. 11, 2025 | Burke William P. Mr. | Director | S | Common Stock | 3591 | $24.02 | 100.0000 | 49,088,436 | 97.29% | 0.01% |
| Nov. 11, 2025 | Burke William P. Mr. | Director | M | Common Stock | 3591 | $8.14 | 3,691.0000 | 49,088,436 | 3591.00% | 0.01% |
| Nov. 10, 2025 | Burke William P. Mr. | Director | S | Common Stock | 19227 | $24.01 | 100.0000 | 49,088,436 | 99.48% | 0.04% |
| Nov. 6, 2025 | Burke William P. Mr. | Director | S | Common Stock | 5347 | $24.01 | 100.0000 | 49,088,436 | 98.16% | 0.01% |
| Nov. 6, 2025 | Burke William P. Mr. | Director | M | Stock Option (right to purchase) | 5347 | $0.00 | 22,818.0000 | 49,088,436 | 18.98% | 0.01% |
| Nov. 5, 2025 | Burke William P. Mr. | Director | M | Common Stock | 11431 | $8.14 | 11,531.0000 | 49,088,436 | 9999.99% | 0.02% |
| Nov. 5, 2025 | Burke William P. Mr. | Director | S | Common Stock | 11431 | $24.05 | 100.0000 | 49,088,436 | 99.13% | 0.02% |
| Nov. 6, 2025 | Burke William P. Mr. | Director | M | Common Stock | 5347 | $8.14 | 5,447.0000 | 49,088,436 | 5347.00% | 0.01% |
| Nov. 5, 2025 | Burke William P. Mr. | Director | M | Stock Option (right to purchase) | 11431 | $0.00 | 28,165.0000 | 49,088,436 | 28.87% | 0.02% |
| Oct. 29, 2025 | Burke William P. Mr. | Director | M | Common Stock | 20436 | $6.30 | 20,536.0000 | 49,088,436 | 9999.99% | 0.04% |
| Oct. 29, 2025 | Burke William P. Mr. | Director | M | Common Stock | 19799 | $8.14 | 19,899.0000 | 49,088,436 | 9999.99% | 0.04% |
| Oct. 29, 2025 | Burke William P. Mr. | Director | S | Common Stock | 20436 | $19.15 | 100.0000 | 49,088,436 | 99.51% | 0.04% |
| Oct. 30, 2025 | Burke William P. Mr. | Director | M | Employee Stock Option (right to purchase) | 18248 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.04% |
| Oct. 29, 2025 | Burke William P. Mr. | Director | M | Stock Option (right to purchase) | 19799 | $0.00 | 39,596.0000 | 49,088,436 | 33.33% | 0.04% |
| Oct. 29, 2025 | Burke William P. Mr. | Director | M | Stock Option (right to buy) | 20436 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.04% |
| Oct. 30, 2025 | Burke William P. Mr. | Director | S | Common Stock | 18248 | $23.00 | 100.0000 | 49,088,436 | 99.45% | 0.04% |
| Oct. 30, 2025 | Burke William P. Mr. | Director | M | Common Stock | 18248 | $7.04 | 18,348.0000 | 49,088,436 | 9999.99% | 0.04% |
| Oct. 29, 2025 | Burke William P. Mr. | Director | S | Common Stock | 19799 | $22.00 | 100.0000 | 49,088,436 | 99.50% | 0.04% |
| Oct. 22, 2025 | Burke William P. Mr. | Director | S | Common Stock | 1457 | $18.02 | 100.0000 | 49,088,436 | 93.58% | 0.00% |
| Oct. 6, 2025 | Burke William P. Mr. | Director | S | Common Stock | 736 | $18.00 | 1,557.0000 | 49,088,436 | 32.10% | 0.00% |
| Oct. 2, 2025 | Burke William P. Mr. | Director | S | Common Stock | 2400 | $18.01 | 9,893.0000 | 49,088,436 | 19.52% | 0.00% |
| Oct. 3, 2025 | Burke William P. Mr. | Director | S | Common Stock | 7600 | $18.21 | 2,293.0000 | 49,088,436 | 76.82% | 0.02% |
| Oct. 2, 2025 | Burke William P. Mr. | Director | S | Common Stock | 7620 | $18.01 | 16,864.0000 | 49,088,436 | 31.12% | 0.02% |
| Oct. 3, 2025 | Burke William P. Mr. | Director | S | Common Stock | 14571 | $18.21 | 2,293.0000 | 49,088,436 | 86.40% | 0.03% |
| Sept. 13, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 2500 | $0.00 | 221,786.0000 | 44,257,754 | 1.14% | 0.01% |
| Sept. 16, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 1137 | $16.29 | 220,649.0000 | 44,257,754 | 0.51% | 0.00% |
| June 19, 2025 | THOMAS PAUL | Director | A | Restricted Stock Units | 18867 | $0.00 | 18,867.0000 | 44,257,754 | 9999.99% | 0.04% |
| June 19, 2025 | TYNDALL JOSEPH A. | Director | A | Restricted Stock Units | 14150 | $0.00 | 14,150.0000 | 44,257,754 | 9999.99% | 0.03% |
| June 19, 2025 | Wendell Amy McBride | Director | A | Restricted Stock Units | 14150 | $0.00 | 14,150.0000 | 44,257,754 | 9999.99% | 0.03% |
| June 19, 2025 | Weiler Kathy Johnson | Director | A | Restricted Stock Units | 14150 | $0.00 | 14,150.0000 | 44,257,754 | 9999.99% | 0.03% |
| June 19, 2025 | Burke William P. Mr. | Director | A | Restricted Stock Units | 14150 | $0.00 | 14,150.0000 | 44,257,754 | 9999.99% | 0.03% |
| June 19, 2025 | Levine Alan M | Director | A | Restricted Stock Units | 14150 | $0.00 | 14,150.0000 | 44,257,754 | 9999.99% | 0.03% |
| June 19, 2025 | JOHNSON JOHN | Director | A | Restricted Stock Units | 14150 | $0.00 | 14,150.0000 | 44,257,754 | 9999.99% | 0.03% |
| June 10, 2025 | TYNDALL JOSEPH A. | Director | M | Common Stock | 4000 | $7.04 | 26,931.0000 | 44,257,754 | 17.44% | 0.01% |
| June 10, 2025 | TYNDALL JOSEPH A. | Director | M | Employee Stock Option (right to purchase) | 4000 | $7.04 | 14,248.0000 | 44,257,754 | 21.92% | 0.01% |
| June 10, 2025 | TYNDALL JOSEPH A. | Director | M | Stock Option (right to purchase) | 7586 | $6.30 | 0.0000 | 44,257,754 | 100.00% | 0.02% |
| June 10, 2025 | TYNDALL JOSEPH A. | Director | S | Common Stock | 26931 | $10.72 | 0.0000 | 44,257,754 | 100.00% | 0.06% |
| June 10, 2025 | TYNDALL JOSEPH A. | Director | M | Common Stock | 7586 | $6.30 | 22,931.0000 | 44,257,754 | 49.44% | 0.02% |
| June 9, 2025 | JOHNSON JOHN | Director | S | Common Stock | 4073 | $10.61 | 24,943.0000 | 44,257,754 | 14.04% | 0.01% |
| June 9, 2025 | NEELS GUIDO J | Director | S | Common Stock | 4073 | $10.61 | 86,743.0000 | 44,257,754 | 4.48% | 0.01% |
| June 9, 2025 | Burke William P. Mr. | Director | S | Common Stock | 4073 | $10.61 | 24,484.0000 | 44,257,754 | 14.26% | 0.01% |
| June 9, 2025 | Wendell Amy McBride | Director | S | Common Stock | 4073 | $10.61 | 93,826.0000 | 44,257,754 | 4.16% | 0.01% |
| June 9, 2025 | Levine Alan M | Director | S | Common Stock | 4073 | $10.61 | 36,743.0000 | 44,257,754 | 9.98% | 0.01% |
| June 9, 2025 | Weiler Kathy Johnson | Director | S | Common Stock | 4073 | $10.61 | 6,580.0000 | 44,257,754 | 38.23% | 0.01% |
| May 22, 2025 | TYNDALL JOSEPH A. | Director | M | Common Stock | 12850 | $6.30 | 35,407.0000 | 44,257,754 | 56.97% | 0.03% |
| May 19, 2025 | TYNDALL JOSEPH A. | Director | S | Common Stock | 2525 | $11.63 | 22,557.0000 | 44,257,754 | 10.07% | 0.01% |
| May 22, 2025 | TYNDALL JOSEPH A. | Director | M | Stock Option (right to purchase) | 12850 | $6.30 | 7,586.0000 | 44,257,754 | 62.88% | 0.03% |
| May 22, 2025 | TYNDALL JOSEPH A. | Director | S | Common Stock | 7212 | $11.20 | 15,345.0000 | 44,257,754 | 31.97% | 0.02% |
| May 22, 2025 | TYNDALL JOSEPH A. | Director | S | Common Stock | 12850 | $11.20 | 22,557.0000 | 44,257,754 | 36.29% | 0.03% |
| May 12, 2025 | Hartley Lindsey Marie | CFO | A | Restricted Stock Units | 26000 | $0.00 | 26,000.0000 | 44,257,754 | 9999.99% | 0.06% |
| March 25, 2025 | DALE MICHAEL D | Chief Executive Officer | A | Restricted Stock Units | 176300 | $0.00 | 176,300.0000 | 44,257,754 | 9999.99% | 0.40% |
| March 25, 2025 | Began Marc A | EVP & General Counsel | A | Restricted Stock Units | 55000 | $0.00 | 55,000.0000 | 44,257,754 | 9999.99% | 0.12% |
| March 25, 2025 | Kemp Jens | Chief Marketing Officer | A | Restricted Stock Units | 38000 | $0.00 | 38,000.0000 | 44,257,754 | 9999.99% | 0.09% |
| March 25, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | A | Restricted Stock Units | 38000 | $0.00 | 38,000.0000 | 44,257,754 | 9999.99% | 0.09% |
| March 16, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 2950 | $0.00 | 0.0000 | 44,257,754 | 100.00% | 0.01% |
| March 16, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 23150 | $0.00 | 23,150.0000 | 44,257,754 | 50.00% | 0.05% |
| March 16, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 6362 | $0.00 | 6,363.0000 | 44,257,754 | 50.00% | 0.01% |
| March 16, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 2950 | $0.00 | 203,361.0000 | 44,257,754 | 1.47% | 0.01% |
| March 16, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 6362 | $0.00 | 209,723.0000 | 44,257,754 | 3.13% | 0.01% |
| March 16, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 23150 | $0.00 | 232,873.0000 | 44,257,754 | 11.04% | 0.05% |
| March 19, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 15111 | $17.50 | 217,762.0000 | 44,257,754 | 6.49% | 0.03% |
| Feb. 22, 2025 | Kemp Jens | Chief Marketing Officer | M | Common Stock | 2500 | $0.00 | 32,500.0000 | 44,257,754 | 8.33% | 0.01% |
| March 1, 2025 | Began Marc A | EVP & General Counsel | M | Common Stock | 22500 | $0.00 | 24,186.0000 | 44,257,754 | 1334.52% | 0.05% |
| March 4, 2025 | Began Marc A | EVP & General Counsel | F | Common Stock | 5901 | $18.36 | 18,285.0000 | 44,257,754 | 24.40% | 0.01% |
| March 1, 2025 | Began Marc A | EVP & General Counsel | M | Restricted Stock Units | 22500 | $0.00 | 22,500.0000 | 44,257,754 | 50.00% | 0.05% |
| March 3, 2025 | Wendell Amy McBride | Director | S | Common Stock | 5000 | $20.02 | 97,899.0000 | 44,257,754 | 4.86% | 0.01% |
| Feb. 25, 2025 | Kemp Jens | Chief Marketing Officer | F | Common Stock | 814 | $16.49 | 31,686.0000 | 44,257,754 | 2.50% | 0.00% |
| March 4, 2025 | Kemp Jens | Chief Marketing Officer | F | Common Stock | 4003 | $18.36 | 27,683.0000 | 44,257,754 | 12.63% | 0.01% |
| Feb. 28, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 24799 | $0.00 | 209,301.0000 | 44,257,754 | 13.44% | 0.06% |
| March 4, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | F | Common Stock | 8296 | $18.35 | 201,005.0000 | 44,257,754 | 3.96% | 0.02% |
| Feb. 25, 2025 | Began Marc A | EVP & General Counsel | F | Common Stock | 814 | $16.50 | 1,686.0000 | 44,257,754 | 32.56% | 0.00% |
| Feb. 25, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | F | Common Stock | 972 | $16.50 | 184,502.0000 | 44,257,754 | 0.52% | 0.00% |
| Feb. 22, 2025 | Kemp Jens | Chief Marketing Officer | M | Common Stock | 2500 | $0.00 | 2,500.0000 | 44,257,754 | 9999.99% | 0.01% |
| Feb. 25, 2025 | Kemp Jens | Chief Marketing Officer | F | Common Stock | 814 | $16.49 | 1,686.0000 | 44,257,754 | 32.56% | 0.00% |
| Feb. 22, 2025 | Began Marc A | EVP & General Counsel | A | Common Stock | 2500 | $0.00 | 2,500.0000 | 44,257,754 | 9999.99% | 0.01% |
| Feb. 22, 2025 | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 2500 | $0.00 | 185,474.0000 | 44,257,754 | 1.37% | 0.01% |
| Jan. 6, 2025 | Naor Nir | CFO | F | Common Stock | 39132 | $15.22 | 260,868.0000 | 44,257,754 | 13.04% | 0.09% |
| Aug. 8, 2024 | TYNDALL JOSEPH A. | Director | P | Common Stock | 2525 | $10.50 | 25,082.0000 | 42,878,543 | 11.19% | 0.01% |
| Sept. 16, 2024 | THOMAS PAUL | Director | A | Common Stock | 2875 | $0.00 | 34,927.0000 | 42,878,543 | 8.97% | 0.01% |
| Sept. 13, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 2500 | $0.00 | 179,974.0000 | 42,878,543 | 1.41% | 0.01% |
| Sept. 1, 2024 | JOHNSON JOHN | Director | M | Common Stock | 11904 | $0.00 | 29,016.0000 | 42,878,543 | 69.57% | 0.03% |
| Sept. 1, 2024 | JOHNSON JOHN | Director | M | Restricted Stock Units | 11904 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.03% |
| Sept. 1, 2024 | NEELS GUIDO J | Director | M | Common Stock | 11904 | $0.00 | 90,816.0000 | 42,878,543 | 15.09% | 0.03% |
| Sept. 1, 2024 | NEELS GUIDO J | Director | M | Restricted Stock Units | 11904 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.03% |
| Sept. 1, 2024 | Levine Alan M | Director | M | Common Stock | 11904 | $0.00 | 40,816.0000 | 42,878,543 | 41.17% | 0.03% |
| Sept. 1, 2024 | Levine Alan M | Director | M | Restricted Stock Units | 11904 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.03% |
| Sept. 1, 2024 | Burke William P. Mr. | Director | M | Common Stock | 11904 | $0.00 | 28,557.0000 | 42,878,543 | 71.48% | 0.03% |
| Sept. 1, 2024 | Burke William P. Mr. | Director | M | Restricted Stock Units | 11904 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.03% |
| Sept. 1, 2024 | THOMAS PAUL | Director | M | Common Stock | 11904 | $0.00 | 32,052.0000 | 42,878,543 | 59.08% | 0.03% |
| Sept. 1, 2024 | THOMAS PAUL | Director | M | Restricted Stock Units | 11904 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.03% |
| Sept. 1, 2024 | TYNDALL JOSEPH A. | Director | M | Restricted Stock Units | 11904 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.03% |
| Sept. 1, 2024 | TYNDALL JOSEPH A. | Director | M | Common Stock | 11904 | $0.00 | 22,557.0000 | 42,878,543 | 111.74% | 0.03% |
| Sept. 1, 2024 | Wendell Amy McBride | Director | M | Restricted Stock Units | 11904 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.03% |
| Sept. 1, 2024 | Wendell Amy McBride | Director | M | Common Stock | 11904 | $0.00 | 102,899.0000 | 42,878,543 | 13.08% | 0.03% |
| Aug. 9, 2024 | DALE MICHAEL D | CEO and President | A | Performance Stock Units | 450000 | $0.00 | 450,000.0000 | 42,878,543 | 9999.99% | 1.05% |
| June 6, 2024 | Weiler Kathy Johnson | Director | A | Common Stock | 10653 | $0.00 | 10,653.0000 | 42,878,543 | 9999.99% | 0.02% |
| June 6, 2024 | TYNDALL JOSEPH A. | Director | A | Employee Stock Option (right to purchase) | 18248 | $0.00 | 18,248.0000 | 42,878,543 | 9999.99% | 0.04% |
| June 6, 2024 | TYNDALL JOSEPH A. | Director | A | Common Stock | 10653 | $0.00 | 10,653.0000 | 42,878,543 | 9999.99% | 0.02% |
| June 6, 2024 | NEELS GUIDO J | Director | A | Employee Stock Option (right to purchase) | 18248 | $0.00 | 18,248.0000 | 42,878,543 | 9999.99% | 0.04% |
| June 6, 2024 | NEELS GUIDO J | Director | A | Common Stock | 10653 | $0.00 | 78,912.0000 | 42,878,543 | 15.61% | 0.02% |
| June 6, 2024 | Levine Alan M | Director | A | Employee Stock Option (right to purchase) | 18248 | $0.00 | 18,248.0000 | 42,878,543 | 9999.99% | 0.04% |
| June 6, 2024 | Levine Alan M | Director | A | Common Stock | 10653 | $0.00 | 28,912.0000 | 42,878,543 | 58.34% | 0.02% |
| June 6, 2024 | THOMAS PAUL | Director | A | Employee Stock Option (right to purchase) | 18248 | $0.00 | 18,248.0000 | 42,878,543 | 9999.99% | 0.04% |
| June 6, 2024 | THOMAS PAUL | Director | A | Common Stock | 10653 | $0.00 | 20,148.0000 | 42,878,543 | 112.20% | 0.02% |
| June 6, 2024 | JOHNSON JOHN | Director | A | Employee Stock Option (right to purchase) | 18248 | $0.00 | 18,248.0000 | 42,878,543 | 9999.99% | 0.04% |
| June 6, 2024 | JOHNSON JOHN | Director | A | Common Stock | 10653 | $0.00 | 17,112.0000 | 42,878,543 | 164.93% | 0.02% |
| June 6, 2024 | Burke William P. Mr. | Director | A | Employee Stock Option (right to purchase) | 18248 | $0.00 | 18,248.0000 | 42,878,543 | 9999.99% | 0.04% |
| June 6, 2024 | Burke William P. Mr. | Director | A | Common Stock | 10653 | $0.00 | 16,653.0000 | 42,878,543 | 177.55% | 0.02% |
| June 6, 2024 | Wendell Amy McBride | Director | A | Stock Option (right to purchase) | 18248 | $0.00 | 18,248.0000 | 42,878,543 | 9999.99% | 0.04% |
| June 6, 2024 | Wendell Amy McBride | Director | A | Common Stock | 10653 | $0.00 | 90,995.0000 | 42,878,543 | 13.26% | 0.02% |
| June 6, 2024 | Weiler Kathy Johnson | Director | A | Employee Stock Option (right to purchase) | 18248 | $0.00 | 18,248.0000 | 42,878,543 | 9999.99% | 0.04% |
| June 4, 2024 | Freitag Gregory Gene | Director | M | Restricted Stock Units | 11904 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.03% |
| June 4, 2024 | Freitag Gregory Gene | Director | M | Common Stock | 11904 | $0.00 | 283,498.0000 | 42,878,543 | 4.38% | 0.03% |
| March 21, 2024 | Scopelianos Angelo | Chief R&D Officer | S | Common Stock | 1020 | $7.68 | 56,104.0000 | 42,878,543 | 1.79% | 0.00% |
| March 21, 2024 | Scopelianos Angelo | Chief R&D Officer | S | Common Stock | 610 | $7.68 | 57,994.0000 | 42,878,543 | 1.04% | 0.00% |
| March 16, 2024 | Scopelianos Angelo | Chief R&D Officer | M | Restricted Stock Units | 21281 | $0.00 | 21,282.0000 | 42,878,543 | 50.00% | 0.05% |
| March 16, 2024 | Scopelianos Angelo | Chief R&D Officer | M | Restricted Stock Units | 4125 | $0.00 | 4,125.0000 | 42,878,543 | 50.00% | 0.01% |
| March 16, 2024 | Scopelianos Angelo | Chief R&D Officer | M | Restricted Stock Units | 2500 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.01% |
| March 16, 2024 | Donovan Michael Patrick | VP Operations | M | Common Stock | 3000 | $0.00 | 38,708.0000 | 42,878,543 | 8.40% | 0.01% |
| March 21, 2024 | Donovan Michael Patrick | VP Operations | S | Common Stock | 716 | $7.68 | 37,992.0000 | 42,878,543 | 1.85% | 0.00% |
| March 16, 2024 | Donovan Michael Patrick | VP Operations | M | Common Stock | 2950 | $0.00 | 40,942.0000 | 42,878,543 | 7.76% | 0.01% |
| March 21, 2024 | Donovan Michael Patrick | VP Operations | S | Common Stock | 721 | $7.68 | 40,221.0000 | 42,878,543 | 1.76% | 0.00% |
| March 16, 2024 | Donovan Michael Patrick | VP Operations | M | Common Stock | 18625 | $0.00 | 58,846.0000 | 42,878,543 | 46.31% | 0.04% |
| March 21, 2024 | Donovan Michael Patrick | VP Operations | S | Common Stock | 4596 | $7.68 | 54,250.0000 | 42,878,543 | 7.81% | 0.01% |
| March 16, 2024 | Donovan Michael Patrick | VP Operations | M | Restricted Stock Units | 3000 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.01% |
| March 16, 2024 | Donovan Michael Patrick | VP Operations | M | Restricted Stock Units | 2950 | $0.00 | 2,950.0000 | 42,878,543 | 50.00% | 0.01% |
| March 16, 2024 | Donovan Michael Patrick | VP Operations | M | Restricted Stock Units | 18625 | $0.00 | 18,625.0000 | 42,878,543 | 50.00% | 0.04% |
| March 16, 2024 | Zaderej Karen L. | CEO | M | Common Stock | 84847 | $0.00 | 1,157,593.0000 | 42,878,543 | 7.91% | 0.20% |
| March 21, 2024 | Zaderej Karen L. | CEO | S | Common Stock | 33028 | $7.68 | 1,124,565.0000 | 42,878,543 | 2.85% | 0.08% |
| March 16, 2024 | Zaderej Karen L. | CEO | M | Common Stock | 12500 | $0.00 | 1,137,065.0000 | 42,878,543 | 1.11% | 0.03% |
| March 21, 2024 | Zaderej Karen L. | CEO | S | Common Stock | 3086 | $7.68 | 1,133,979.0000 | 42,878,543 | 0.27% | 0.01% |
| March 16, 2024 | Zaderej Karen L. | CEO | M | Common Stock | 12975 | $0.00 | 1,146,954.0000 | 42,878,543 | 1.14% | 0.03% |
| March 21, 2024 | Zaderej Karen L. | CEO | S | Common Stock | 3166 | $7.68 | 1,143,788.0000 | 42,878,543 | 0.28% | 0.01% |
| March 16, 2024 | Zaderej Karen L. | CEO | M | Restricted Stock Units | 84847 | $0.00 | 84,847.0000 | 42,878,543 | 50.00% | 0.20% |
| March 16, 2024 | Zaderej Karen L. | CEO | M | Restricted Stock Units | 12500 | $0.00 | 12,500.0000 | 42,878,543 | 50.00% | 0.03% |
| March 16, 2024 | Zaderej Karen L. | CEO | M | Restricted Stock Units | 12975 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.03% |
| March 16, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 3000 | $0.00 | 166,377.0000 | 42,878,543 | 1.84% | 0.01% |
| March 21, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 716 | $7.68 | 165,661.0000 | 42,878,543 | 0.43% | 0.00% |
| March 16, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 2950 | $0.00 | 168,611.0000 | 42,878,543 | 1.78% | 0.01% |
| March 21, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 721 | $7.68 | 167,890.0000 | 42,878,543 | 0.43% | 0.00% |
| March 16, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | M | Common Stock | 12725 | $0.00 | 180,615.0000 | 42,878,543 | 7.58% | 0.03% |
| March 21, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | S | Common Stock | 3141 | $7.68 | 177,474.0000 | 42,878,543 | 1.74% | 0.01% |
| March 16, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 3000 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.01% |
| March 16, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 2950 | $0.00 | 2,950.0000 | 42,878,543 | 50.00% | 0.01% |
| March 16, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | M | Restricted Stock Units | 12725 | $0.00 | 12,725.0000 | 42,878,543 | 50.00% | 0.03% |
| March 16, 2024 | Scopelianos Angelo | Chief R&D Officer | M | Common Stock | 21281 | $0.00 | 58,250.0000 | 42,878,543 | 57.56% | 0.05% |
| March 21, 2024 | Scopelianos Angelo | Chief R&D Officer | S | Common Stock | 5251 | $7.68 | 52,999.0000 | 42,878,543 | 9.01% | 0.01% |
| March 16, 2024 | Scopelianos Angelo | Chief R&D Officer | M | Common Stock | 4125 | $0.00 | 57,124.0000 | 42,878,543 | 7.78% | 0.01% |
| March 21, 2024 | Scopelianos Angelo | Chief R&D Officer | M | Common Stock | 2500 | $0.00 | 58,604.0000 | 42,878,543 | 4.46% | 0.01% |
| March 7, 2024 | Donovan Michael Patrick | VP Operations | S | Common Stock | 36310 | $8.81 | 35,708.0000 | 42,878,543 | 50.42% | 0.08% |
| March 7, 2024 | Freitag Gregory Gene | Director | S | Common Stock | 25000 | $9.00 | 271,594.0000 | 42,878,543 | 8.43% | 0.06% |
| March 1, 2024 | DeVinney Erick Wayne | Chief Innovation Officer | A | Common Stock | 50000 | $0.00 | 163,377.0000 | 42,878,543 | 44.10% | 0.12% |
| Feb. 22, 2024 | Kemp Jens | Chief Marketing Officer | A | Performance Stock Units | 68600 | $0.00 | 68,600.0000 | 42,878,543 | 9999.99% | 0.16% |
| Feb. 22, 2024 | DeVinney Erick Wayne | VP Peripheral Nerve Science | A | Performance Stock Units | 68600 | $0.00 | 68,600.0000 | 42,878,543 | 9999.99% | 0.16% |
| Feb. 22, 2024 | Began Marc A | EVP and General Counsel | A | Performance Stock Units | 68600 | $0.00 | 68,600.0000 | 42,878,543 | 9999.99% | 0.16% |
| Dec. 20, 2023 | Weiler Kathy Johnson | Director | A | Stock Option (right to purchase) | 65476 | $6.95 | 65,476.0000 | 42,083,125 | 9999.99% | 0.16% |
| Jan. 1, 2024 | Naor Nir | CFO | A | Common Stock | 300000 | $0.00 | 300,000.0000 | 42,878,543 | 9999.99% | 0.70% |
| Dec. 11, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | S | Common Stock | 7970 | $7.50 | 63,603.0000 | 42,083,125 | 11.14% | 0.02% |
| Dec. 11, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | S | Common Stock | 3120 | $7.51 | 71,573.0000 | 42,083,125 | 4.18% | 0.01% |
| Dec. 11, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | S | Common Stock | 1410 | $7.52 | 74,693.0000 | 42,083,125 | 1.85% | 0.00% |
| July 18, 2023 | Scopelianos Angelo | Chief R&D Officer | A | Common Stock | 2571 | $0.00 | 38,372.0000 | 42,083,125 | 7.18% | 0.01% |
| July 18, 2023 | Donovan Michael Patrick | VP Operations | A | Common Stock | 2571 | $0.00 | 73,421.0000 | 42,083,125 | 3.63% | 0.01% |
| Oct. 13, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | D | Common Stock | 864 | $4.04 | 113,377.0000 | 42,083,125 | 0.76% | 0.00% |
| July 18, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | A | Common Stock | 1579 | $0.00 | 114,241.0000 | 42,083,125 | 1.40% | 0.00% |
| Oct. 13, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | D | Common Stock | 3263 | $4.04 | 76,103.0000 | 42,083,125 | 4.11% | 0.01% |
| July 18, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | A | Common Stock | 3709 | $0.00 | 79,366.0000 | 42,083,125 | 4.90% | 0.01% |
| Oct. 13, 2023 | Donovan Michael Patrick | VP Operations | D | Common Stock | 1403 | $4.04 | 72,018.0000 | 42,083,125 | 1.91% | 0.00% |
| July 18, 2023 | Zaderej Karen L. | CEO | A | Common Stock | 22076 | $0.00 | 1,072,746.0000 | 42,083,125 | 2.10% | 0.05% |
| Oct. 13, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | D | Common Stock | 1403 | $4.04 | 30,476.0000 | 42,083,125 | 4.40% | 0.00% |
| July 18, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | A | Common Stock | 2571 | $0.00 | 31,879.0000 | 42,083,125 | 8.77% | 0.01% |
| Oct. 13, 2023 | Scopelianos Angelo | Chief R&D Officer | D | Common Stock | 1403 | $4.04 | 36,969.0000 | 42,083,125 | 3.66% | 0.00% |
| Sept. 6, 2023 | Wendell Amy McBride | Director | P | Common Stock | 10000 | $6.22 | 80,342.0000 | 42,083,125 | 14.22% | 0.02% |
| Sept. 1, 2023 | TYNDALL JOSEPH A. | Director | A | Restricted Stock Units | 11904 | $0.00 | 11,904.0000 | 42,083,125 | 9999.99% | 0.03% |
| Sept. 1, 2023 | Wendell Amy McBride | Director | A | Stock Option (right to purchase) | 20436 | $0.00 | 20,436.0000 | 42,083,125 | 9999.99% | 0.05% |
| Sept. 1, 2023 | Wendell Amy McBride | Director | A | Restricted Stock Units | 11904 | $0.00 | 11,904.0000 | 42,083,125 | 9999.99% | 0.03% |
| Sept. 1, 2023 | Burke William P. Mr. | Director | A | Employee Stock Option (right to purchase) | 20436 | $0.00 | 20,436.0000 | 42,083,125 | 9999.99% | 0.05% |
| Sept. 1, 2023 | Burke William P. Mr. | Director | A | Common Stock | 11904 | $0.00 | 11,904.0000 | 42,083,125 | 9999.99% | 0.03% |
| Sept. 1, 2023 | TYNDALL JOSEPH A. | Director | A | Stock Option (right to purchase) | 20436 | $0.00 | 20,436.0000 | 42,083,125 | 9999.99% | 0.05% |
| Sept. 1, 2023 | THOMAS PAUL | Director | A | Employee Stock Option (right to purchase) | 20436 | $0.00 | 20,436.0000 | 42,083,125 | 9999.99% | 0.05% |
| Sept. 1, 2023 | THOMAS PAUL | Director | A | Restricted Stock Units | 11904 | $0.00 | 11,904.0000 | 42,083,125 | 9999.99% | 0.03% |
| Sept. 1, 2023 | JOHNSON JOHN | Director | A | Stock Option (right to purchase) | 20436 | $0.00 | 20,436.0000 | 42,083,125 | 9999.99% | 0.05% |
| Sept. 1, 2023 | JOHNSON JOHN | Director | A | Restricted Stock Units | 11904 | $0.00 | 11,904.0000 | 42,083,125 | 9999.99% | 0.03% |
| Sept. 1, 2023 | Freitag Gregory Gene | Director | A | Stock Option (right to purchase) | 20436 | $0.00 | 20,436.0000 | 42,083,125 | 9999.99% | 0.05% |
| Sept. 1, 2023 | Freitag Gregory Gene | Director | A | Restricted Stock Units | 11904 | $0.00 | 11,904.0000 | 42,083,125 | 9999.99% | 0.03% |
| Sept. 1, 2023 | Levine Alan M | Director | A | Stock Option (right to purchase) | 20436 | $0.00 | 20,436.0000 | 42,083,125 | 9999.99% | 0.05% |
| Sept. 1, 2023 | Levine Alan M | Director | A | Restricted Stock Units | 11904 | $0.00 | 11,904.0000 | 42,083,125 | 9999.99% | 0.03% |
| Sept. 1, 2023 | NEELS GUIDO J | Director | A | Stock Option (right to purchase) | 20436 | $0.00 | 20,436.0000 | 42,083,125 | 9999.99% | 0.05% |
| Sept. 1, 2023 | NEELS GUIDO J | Director | A | Restricted Stock Units | 11904 | $0.00 | 11,904.0000 | 42,083,125 | 9999.99% | 0.03% |
| Aug. 23, 2023 | Burke William P. Mr. | Director | P | Common Stock | 10000 | $6.56 | 16,000.0000 | 42,083,125 | 166.67% | 0.02% |
| Aug. 24, 2023 | Burke William P. Mr. | Director | A | Common Stock | 6000 | $6.31 | 16,000.0000 | 42,083,125 | 60.00% | 0.01% |
| Aug. 16, 2023 | NEELS GUIDO J | Director | P | Common Stock | 10000 | $6.11 | 68,259.0000 | 42,083,125 | 17.16% | 0.02% |
| June 1, 2023 | Wendell Amy McBride | Director | M | Restricted Stock Units | 6459 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.02% |
| June 1, 2023 | THOMAS PAUL | Director | M | Common Stock | 6459 | $0.00 | 9,495.0000 | 42,083,125 | 212.75% | 0.02% |
| June 1, 2023 | THOMAS PAUL | Director | M | Restricted Stock Units | 6459 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.02% |
| June 1, 2023 | NEELS GUIDO J | Director | M | Restricted Stock Units | 6459 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.02% |
| June 1, 2023 | Freitag Gregory Gene | Director | S | Common Stock | 12500 | $8.65 | 319,615.0000 | 42,083,125 | 3.76% | 0.03% |
| June 1, 2023 | Freitag Gregory Gene | Director | S | Common Stock | 29480 | $8.74 | 290,135.0000 | 42,083,125 | 9.22% | 0.07% |
| June 1, 2023 | Freitag Gregory Gene | Director | M | Common Stock | 6459 | $0.00 | 296,594.0000 | 42,083,125 | 2.23% | 0.02% |
| June 1, 2023 | Freitag Gregory Gene | Director | M | Restricted Stock Units | 6459 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.02% |
| June 1, 2023 | Wendell Amy McBride | Director | M | Common Stock | 6459 | $0.00 | 70,342.0000 | 42,083,125 | 10.11% | 0.02% |
| June 1, 2023 | Levine Alan M | Director | M | Common Stock | 6459 | $0.00 | 18,259.0000 | 42,083,125 | 54.74% | 0.02% |
| June 1, 2023 | Levine Alan M | Director | M | Restricted Stock Units | 6459 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.02% |
| June 1, 2023 | JOHNSON JOHN | Director | M | Common Stock | 6459 | $0.00 | 6,459.0000 | 42,083,125 | 9999.99% | 0.02% |
| June 1, 2023 | JOHNSON JOHN | Director | M | Restricted Stock Units | 6459 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.02% |
| June 1, 2023 | NEELS GUIDO J | Director | M | Common Stock | 6459 | $0.00 | 58,259.0000 | 42,083,125 | 12.47% | 0.02% |
| May 23, 2023 | Freitag Gregory Gene | Director | S | Common Stock | 2828 | $9.17 | 336,755.0000 | 42,083,125 | 0.83% | 0.01% |
| May 23, 2023 | Freitag Gregory Gene | Director | S | Common Stock | 4640 | $9.26 | 332,115.0000 | 42,083,125 | 1.38% | 0.01% |
| May 12, 2023 | Wendell Amy McBride | Director | M | Stock Option (right to buy) | 3750 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.01% |
| May 12, 2023 | Wendell Amy McBride | Director | M | Stock Option (right to buy) | 25000 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.06% |
| May 12, 2023 | Wendell Amy McBride | Director | M | Common Stock | 3750 | $9.22 | 63,883.0000 | 42,083,125 | 6.24% | 0.01% |
| May 12, 2023 | Wendell Amy McBride | Director | M | Common Stock | 25000 | $9.22 | 60,133.0000 | 42,083,125 | 71.16% | 0.06% |
| March 16, 2023 | Ottinger Bradley | General Counsel and CCO | F | Common Stock | 798 | $8.27 | 22,900.0000 | 42,083,125 | 3.37% | 0.00% |
| March 16, 2023 | Ottinger Bradley | General Counsel and CCO | M | Common Stock | 5900 | $0.00 | 23,698.0000 | 42,083,125 | 33.15% | 0.01% |
| March 16, 2023 | Zaderej Karen L. | CEO | A | Restricted Stock Units | 112000 | $0.00 | 112,000.0000 | 42,083,125 | 9999.99% | 0.27% |
| March 16, 2023 | Zaderej Karen L. | CEO | A | Employee Stock Option (right to purchase) | 179000 | $0.00 | 179,000.0000 | 42,083,125 | 9999.99% | 0.43% |
| March 16, 2023 | Zaderej Karen L. | CEO | M | Restricted Stock Units | 12975 | $0.00 | 12,975.0000 | 42,083,125 | 50.00% | 0.03% |
| March 16, 2023 | Zaderej Karen L. | CEO | M | Restricted Stock Units | 25000 | $0.00 | 25,000.0000 | 42,083,125 | 50.00% | 0.06% |
| March 16, 2023 | Zaderej Karen L. | CEO | M | Common Stock | 12975 | $0.00 | 1,050,670.0000 | 42,083,125 | 1.25% | 0.03% |
| March 16, 2023 | Zaderej Karen L. | CEO | M | Common Stock | 25000 | $0.00 | 1,037,695.0000 | 42,083,125 | 2.47% | 0.06% |
| March 16, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | A | Restricted Stock Units | 46300 | $0.00 | 46,300.0000 | 42,083,125 | 9999.99% | 0.11% |
| March 16, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | A | Employee Stock Option (right to purchase) | 64000 | $0.00 | 64,000.0000 | 42,083,125 | 9999.99% | 0.15% |
| March 16, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | M | Restricted Stock Units | 3000 | $0.00 | 3,000.0000 | 42,083,125 | 9999.99% | 0.01% |
| March 16, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | M | Restricted Stock Units | 5900 | $0.00 | 5,900.0000 | 42,083,125 | 9999.99% | 0.01% |
| March 16, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | F | Common Stock | 934 | $8.27 | 112,662.0000 | 42,083,125 | 0.82% | 0.00% |
| March 16, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | M | Common Stock | 3000 | $0.00 | 113,596.0000 | 42,083,125 | 2.71% | 0.01% |
| March 16, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | F | Common Stock | 1835 | $8.27 | 110,596.0000 | 42,083,125 | 1.63% | 0.00% |
| March 16, 2023 | DeVinney Erick Wayne | VP Peripheral Nerve Science | M | Common Stock | 5900 | $0.00 | 112,431.0000 | 42,083,125 | 5.54% | 0.01% |
| March 16, 2023 | Donovan Michael Patrick | VP Operations | A | Restricted Stock Units | 48500 | $0.00 | 48,500.0000 | 42,083,125 | 9999.99% | 0.12% |
| March 16, 2023 | Donovan Michael Patrick | VP Operations | A | Employee Stock Option (right to purchase) | 63500 | $0.00 | 63,500.0000 | 42,083,125 | 9999.99% | 0.15% |
| March 16, 2023 | Donovan Michael Patrick | VP Operations | M | Restricted Stock Units | 5900 | $0.00 | 5,900.0000 | 42,083,125 | 50.00% | 0.01% |
| March 16, 2023 | Donovan Michael Patrick | VP Operations | M | Restricted Stock Units | 3000 | $0.00 | 3,000.0000 | 42,083,125 | 50.00% | 0.01% |
| March 16, 2023 | Donovan Michael Patrick | VP Operations | F | Common Stock | 1835 | $8.27 | 70,850.0000 | 42,083,125 | 2.52% | 0.00% |
| March 16, 2023 | Donovan Michael Patrick | VP Operations | M | Common Stock | 5900 | $0.00 | 72,685.0000 | 42,083,125 | 8.83% | 0.01% |
| March 16, 2023 | Scopelianos Angelo | Chief R&D Officer | M | Restricted Stock Units | 2500 | $0.00 | 2,500.0000 | 42,083,125 | 50.00% | 0.01% |
| March 16, 2023 | Donovan Michael Patrick | VP Operations | M | Common Stock | 3000 | $0.00 | 67,719.0000 | 42,083,125 | 4.64% | 0.01% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | A | Employee Stock Option (right to purchase) | 46300 | $0.00 | 46,300.0000 | 42,083,125 | 9999.99% | 0.11% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | A | Employee Stock Option (right to purchase) | 66500 | $0.00 | 66,500.0000 | 42,083,125 | 9999.99% | 0.16% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | M | Restricted Stock Units | 5900 | $0.00 | 5,900.0000 | 42,083,125 | 9999.99% | 0.01% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | M | Restricted Stock Units | 4367 | $0.00 | 4,367.0000 | 42,083,125 | 9999.99% | 0.01% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | M | Restricted Stock Units | 1250 | $0.00 | 1,250.0000 | 42,083,125 | 9999.99% | 0.00% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | M | Restricted Stock Units | 3000 | $0.00 | 3,000.0000 | 42,083,125 | 9999.99% | 0.01% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | F | Common Stock | 1590 | $8.27 | 29,308.0000 | 42,083,125 | 5.15% | 0.00% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | M | Common Stock | 5900 | $0.00 | 30,898.0000 | 42,083,125 | 23.60% | 0.01% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | F | Common Stock | 1358 | $8.27 | 24,998.0000 | 42,083,125 | 5.15% | 0.00% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | M | Common Stock | 4367 | $0.00 | 26,356.0000 | 42,083,125 | 19.86% | 0.01% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | F | Common Stock | 389 | $8.27 | 21,989.0000 | 42,083,125 | 1.74% | 0.00% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | M | Common Stock | 1250 | $0.00 | 22,378.0000 | 42,083,125 | 5.92% | 0.00% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | F | Common Stock | 933 | $8.27 | 21,128.0000 | 42,083,125 | 4.23% | 0.00% |
| March 16, 2023 | MARTINEZ MARIA D. | Chief Human Resources Officer | M | Common Stock | 3000 | $0.00 | 22,061.0000 | 42,083,125 | 15.74% | 0.01% |
| March 16, 2023 | Donovan Michael Patrick | VP Operations | F | Common Stock | 934 | $8.27 | 66,785.0000 | 42,083,125 | 1.38% | 0.00% |
| March 16, 2023 | Scopelianos Angelo | Chief R&D Officer | A | Employee Stock Option (right to purchase) | 78000 | $0.00 | 78,000.0000 | 42,083,125 | 9999.99% | 0.19% |
| March 16, 2023 | Scopelianos Angelo | Chief R&D Officer | A | Restricted Stock Units | 54100 | $0.00 | 54,100.0000 | 42,083,125 | 9999.99% | 0.13% |
| March 16, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Common Stock | 5500 | $0.00 | 67,445.0000 | 42,083,125 | 8.88% | 0.01% |
| March 16, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | F | Common Stock | 1866 | $8.27 | 65,579.0000 | 42,083,125 | 2.77% | 0.00% |
| March 16, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Common Stock | 15250 | $0.00 | 80,829.0000 | 42,083,125 | 23.25% | 0.04% |
| March 16, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | F | Common Stock | 5172 | $8.27 | 75,657.0000 | 42,083,125 | 6.40% | 0.01% |
| March 16, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Restricted Stock Units | 5500 | $0.00 | 5,500.0000 | 42,083,125 | 50.00% | 0.01% |
| March 16, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Restricted Stock Units | 15250 | $0.00 | 15,250.0000 | 42,083,125 | 50.00% | 0.04% |
| March 16, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | A | Employee Stock Option (right to purchase) | 94500 | $0.00 | 94,500.0000 | 42,083,125 | 9999.99% | 0.22% |
| March 16, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | A | Restricted Stock Units | 65600 | $0.00 | 65,600.0000 | 42,083,125 | 9999.99% | 0.16% |
| March 16, 2023 | Scopelianos Angelo | Chief R&D Officer | M | Restricted Stock Units | 3000 | $0.00 | 3,000.0000 | 42,083,125 | 50.00% | 0.01% |
| March 16, 2023 | Scopelianos Angelo | Chief R&D Officer | M | Restricted Stock Units | 8250 | $0.00 | 8,250.0000 | 42,083,125 | 50.00% | 0.02% |
| March 16, 2023 | Scopelianos Angelo | Chief R&D Officer | F | Common Stock | 933 | $8.27 | 35,801.0000 | 42,083,125 | 2.54% | 0.00% |
| March 16, 2023 | Scopelianos Angelo | Chief R&D Officer | F | Common Stock | 778 | $8.27 | 36,734.0000 | 42,083,125 | 2.07% | 0.00% |
| March 16, 2023 | Scopelianos Angelo | Chief R&D Officer | F | Common Stock | 2196 | $8.27 | 37,512.0000 | 42,083,125 | 5.53% | 0.01% |
| March 16, 2023 | Scopelianos Angelo | Chief R&D Officer | M | Common Stock | 2500 | $0.00 | 39,708.0000 | 42,083,125 | 6.72% | 0.01% |
| March 16, 2023 | Scopelianos Angelo | Chief R&D Officer | M | Common Stock | 3000 | $0.00 | 37,208.0000 | 42,083,125 | 8.77% | 0.01% |
| March 16, 2023 | Scopelianos Angelo | Chief R&D Officer | M | Common Stock | 8250 | $0.00 | 34,208.0000 | 42,083,125 | 31.78% | 0.02% |
| March 16, 2023 | Ottinger Bradley | General Counsel and CCO | M | Restricted Stock Units | 2563 | $0.00 | 2,564.0000 | 42,083,125 | 49.99% | 0.01% |
| March 16, 2023 | Ottinger Bradley | General Counsel and CCO | M | Restricted Stock Units | 5900 | $0.00 | 5,900.0000 | 42,083,125 | 50.00% | 0.01% |
| March 16, 2023 | Ottinger Bradley | General Counsel and CCO | F | Common Stock | 1836 | $8.27 | 23,627.0000 | 42,083,125 | 7.21% | 0.00% |
| March 16, 2023 | Ottinger Bradley | General Counsel and CCO | M | Common Stock | 2563 | $0.00 | 25,463.0000 | 42,083,125 | 11.19% | 0.01% |
| Jan. 30, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Common Stock | 20939 | $5.04 | 63,047.0000 | 42,083,125 | 49.73% | 0.05% |
| Feb. 1, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Employee Stock Option (right to purchase) | 20940 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.05% |
| Jan. 31, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Employee Stock Option (right to purchase) | 20939 | $0.00 | 20,940.0000 | 42,083,125 | 50.00% | 0.05% |
| Jan. 30, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Employee Stock Option (right to purchase) | 20939 | $0.00 | 41,879.0000 | 42,083,125 | 33.33% | 0.05% |
| Feb. 1, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | S | Common Stock | 14550 | $9.36 | 61,945.0000 | 42,083,125 | 19.02% | 0.03% |
| Feb. 1, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Common Stock | 20940 | $5.04 | 76,495.0000 | 42,083,125 | 37.69% | 0.05% |
| Jan. 31, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | S | Common Stock | 14320 | $9.55 | 55,555.0000 | 42,083,125 | 20.49% | 0.03% |
| Jan. 31, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Common Stock | 20939 | $5.04 | 69,875.0000 | 42,083,125 | 42.79% | 0.05% |
| Jan. 30, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | S | Common Stock | 14111 | $9.69 | 48,936.0000 | 42,083,125 | 22.38% | 0.03% |
| Jan. 27, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Employee Stock Option (right to purchase) | 20940 | $0.00 | 62,818.0000 | 42,083,125 | 25.00% | 0.05% |
| Jan. 26, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Employee Stock Option (right to purchase) | 20939 | $0.00 | 83,758.0000 | 42,083,125 | 20.00% | 0.05% |
| Jan. 25, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Employee Stock Option (right to purchase) | 20939 | $0.00 | 104,697.0000 | 42,083,125 | 16.67% | 0.05% |
| Jan. 27, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | S | Common Stock | 20940 | $10.16 | 42,108.0000 | 42,083,125 | 33.21% | 0.05% |
| Jan. 27, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Common Stock | 20940 | $5.04 | 63,048.0000 | 42,083,125 | 49.73% | 0.05% |
| Jan. 26, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | S | Common Stock | 20939 | $9.90 | 42,108.0000 | 42,083,125 | 33.21% | 0.05% |
| Jan. 26, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Common Stock | 20939 | $5.04 | 63,047.0000 | 42,083,125 | 49.73% | 0.05% |
| Jan. 25, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | S | Common Stock | 20939 | $10.23 | 42,108.0000 | 42,083,125 | 33.21% | 0.05% |
| Jan. 25, 2023 | MARIANI PETER J | EVP & Chief Financial Officer | M | Common Stock | 20939 | $5.04 | 63,047.0000 | 42,083,125 | 49.73% | 0.05% |